Not logged in...
About USC Norris
FAQ - Trials
Contact Us - Trials
Support USC Norris
» Contact Us
If you are a patient, please contact
Keck Medical Center of USC
A Phase III, Randomized, Double-Blind, Controlled Study of Cabozantinib (XL184) vs. Prednisone in Metastatic Castration-Resistant Prostate Cancer Patients Who Have Received Prior Docetaxel and Prior Abiraterone or MDV3100.
Not Open (Closed)
Anti-Angiogenesis, Biological Response Modifier
Defintions of terms and FAQ about clinical trials.
Tanya Dorff, M.D.
Other Trial Staff:
Charlean Ketchens, R.N., Lagrimas Ilagan, D.M., Roberto Tejada, D.M., Kristy Sartor Massopust, Coordinator, Olga Castellanos, Coordinator, Elysse Faye Ballon, Coordinator
to see study documents.
Click here to see trial eligibility criteria and further details at ClinicalTrials.gov
For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or
To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3111.